Chemoinformaics analysis of GALLOYLQUINIC-ACID
| Molecular Weight | 628.762 | nRot | 8 |
| Heavy Atom Molecular Weight | 584.41 | nRig | 33 |
| Exact Molecular Weight | 628.304 | nRing | 7 |
| Solubility: LogS | -3.117 | nHRing | 3 |
| Solubility: LogP | 7.952 | No. of Aliphatic Rings | 6 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 90 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 38 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 99.2149 |
| nHD | 2 | BPOL | 51.9531 |
| QED | 0.293 |
| Synth | 6.968 |
| Natural Product Likeliness | 3.089 |
| NR-PPAR-gamma | 0.857 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.713 |
| Pgp-sub | 0.028 |
| HIA | 0.544 |
| CACO-2 | -4.865 |
| MDCK | 0.0000187 |
| BBB | 0.112 |
| PPB | 0.933945 |
| VDSS | 1.468 |
| FU | 0.0619144 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.313 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.662 |
| CYP2c9-inh | 0.348 |
| CYP2c9-sub | 0.27 |
| CYP2d6-inh | 0.347 |
| CYP2d6-sub | 0.066 |
| CYP3a4-inh | 0.643 |
| CYP3a4-sub | 0.787 |
| CL | 2.618 |
| T12 | 0.014 |
| hERG | 0.098 |
| Ames | 0.005 |
| ROA | 0.994 |
| SkinSen | 0.057 |
| Carcinogencity | 0.913 |
| EI | 0.006 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.948 |
| Antiviral | Yes |
| Prediction | 0.812162 |